Effect of glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effects

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 1, 1998, Pages 231-239

  Šrám, Radim J ^a,b  

^a Regional Institute of Hygiene   (Czech Republic)

^b INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

Biomarkers of effects; Biomarkers of exposure; Environmental exposure; GSTM1; Occupational exposure

Indexed keywords

BENZIDINE; BIOLOGICAL MARKER; GLUTATHIONE TRANSFERASE; PESTICIDE; POLYCYCLIC AROMATIC HYDROCARBON;

AIR POLLUTION; AUTOPSY; CHROMOSOME ABERRATION; DNA ADDUCT; DONOR; FIRE FIGHTER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG PARENCHYMA; MICRONUCLEUS; MOTHER; MUTAGENICITY; POPULATION EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SISTER CHROMATID EXCHANGE; SMOKING; URINALYSIS;

EID: 0344583441     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.106-1533289     Document Type: Review

References (92)

1. Doll R, Peto R. The Causes of Cancer. Quantitative Estimates of Avoidable Risks of Cancer in the United States Today. Oxford:Oxford University Press, 1981.
2. Perera FP, Santella R. Carcinogenesis. In: Molecular Epidemiology, Principle and Practices (Schulte PA, Perera FP, eds). San Diego, CA:Academic Press, 1993:277-300.
3. Idle JR. Is environmental carcinogenesis modulated by host polymorphism? Mutat Res 24:259-266 (1991).
4. Nebert DW. Role of genetics and drug metabolism in human cancer risk. Mutat Res 247:267-281 (1991).
5. Harris CC. Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res Suppl 51:5023s-5044s (1991).
6. Hirvonen A. Genetic factors in individual responses to environmental exposures. Occup Environ Med 37:37-43 (1995).
7. Hirvonen A. Combinations of susceptible genotypes and individual responses to toxicants. Environ Health Perspect 105(Suppl 4):1-4 (1997).
8. Bartsch H, Hietanen E. The role of individual susceptibility in cancer burden elated to environmental exposure. Environ Health Perspect 104(Suppl 3):569-577 (1996).
9. Albertini R, Nicklas JA, O'Neill JP. Future research directions for evaluating human genetic and cancer risk from environmental exposures. Environ Health Perspect 104(Suppl 3):503-510 (1996).
10. Barrett JC, Vainio H, Peakall D, Goldstein BD, 12th Meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals: susceptibility to environmental hazards. Environ Health Perspect 105(Suppl 4):699-737 (1997).
11. Olden K. Thinking big: four ways to advance environmental health research to answer the needs of public policy. Environ Health Perspect 105:464-465 (1997).
12. Jacoby WB. The glutathione-S-transferase, a group of multifunctional detoxification proteins. Adv Enzymol Rel Areas Mol Biol 46:383-414 (1978).
13. Sies H, Ketterer B. Glutathione Conjugation: Mechanisms and Biological Significance, New York:Academy Press, 1988.
14. Coles B, Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Grit Rev Biochem Mol Biol 25:47 (1990).
15. Seidegard J, Ekström G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect 105(Suppl 4):791-799 (1997).
16. Warholm M, Guthenberg C, Mannervik B. Molecular and catalytic properties of glutathione S-transferase μ from human liver: an enzyme efficiently conjugating epoxides. Biochemistry 22:3610-3617 (1983).
17. Liu YH, Taylor J, Linko P, Lucier GW, Thompson CL. Glutathione S-transferase μ in lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts. Carcinogenesis 12:2269-2275 (1991).
18. Klone A, Weidner U, Hussnatter R, Harris J, Meyer D, Peter S, Ketterer B, Sies H. Decreased expression of the glutathione-S-transferases alpha and pi genes in human renal cell carcinoma. Carcinogenesis 11:2179-2183 (1990).
19. Zhong S, Howie AF, Ketterer B, Taylor J, Hayes JD, Beckett GJ, Wathen CG, Wolf CR, Spurr NK. Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 12:1533-1537 (1991).
20. Ketterer B, Harris JM, Talaska G, Meyer DJ, Pemble SE, Taylor JB, Lang NP, Kadlubar FF. The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect 98:87-94 (1992).
21. Warwick A, Sarhanis P, Redman C, Pemble S, Taylor JB, Ketterer B, Jones P, Alldersea J, Gilford J, Yengi L. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interaction with GSTM1, CYP2D6 and smoking. Carcinogenesis 15:2841-2845 (1994).
22. Anttila S, Luostarinen L, Hirvonen A, Elovaara E, Karjalainen A, Nurminen T, Hayes JD, Vainio H, Ketterer B. Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking, and asbestos exposure. Cancer Res 55:3305-3309 (1995).
23. Nakajima T, Elovaara E, Anttila S, Hirvonen A, Camus AM, Hayes JD, Ketterer B, Vainio H. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis 16:707-711 (1995).
24. Meyer DJ, Coles B, Pemble SE, Gilmore KS, Fraser GM, Ketterer B. Theta, a new class of glutathione transferases purified from rat and man. Biochem J 274:409-414 (1991).
25. Hussey AJ, Hayes JD. Characterisation of a human class theta glutathione S-transferase with activity towards 1-menaphthyl sulfate. Biochem J 286:929-935 (1992).
26. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB. Human giutathione S-transferase theta (GSTT1): cDNA cloning and the characterisation of a genetic polymorphism. Biochem J 300:271-276 (1994).
27. Seidegard J, Pero RW, Miller DG, Beattie EJ. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 7:751-753 (1986).
28. McWilliams JE, Sanderson BJS, Harris EL, Richert-Boe KE, Henner WD. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 4:589-594 (1995).
29. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ. Isoenzyrne of glutathione transferase (class μ) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis 11:33-36 (1990).
30. Zhong S, Howie AF, Ketterer B, Taylor J, Hayes JD, Beckett GJ, Wathen CG, Wolf CR, Spurr NK. Glutathione S-transferase μ locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 12:1533-1537 (1991).
31. Zhong S, Hayes JD, Spurr NK, Wolf CR. Molecular genetics of the human μ class GST gene family. In: Structure and Function of Glutathione Transferases (Tew KD, Pickett CB, Mantle TJ, Mannervik B, Hayes JD, eds). Boca Raton, FL:CRC Press, 1993.
32. Hayashi SI, Watanabe J, Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IAJ and μ-class glutathione S-transferase genes. Jpn J Cancer Res 83:866-870 (1992).
33. Heckbert SR, Weiss NS, Hornung SK, Eaton DL, Motulsky AG. Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancer. J Natl Cancer Inst 84:414-422 (1992).
34. Brockmöller J, Kerb R, Drakoulis N, Nitz M, Roots I. Genotype and phenotype of glutathione S-transferase class μ isoenzymes μ and in lung cancer patients and controls. Cancer Res 53:1004-1011 (1993).
35. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 14:1479-1481 (1993).
36. Nazar-Stewart V, Motulsky AG, Eaton DL, White E, Hornung SK, Leng ZT, Stapelton P, Weiss NS. The glutathione S-transferase μ polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 53:2313-2318 (1993).
37. Alexandrie AK, Sundberg MI, Seidegard J, Tornling G, Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 15:1785-1790 (1994).
38. Kihara M, Kihara M, Noda K. Lung cancer risk of GSTM1 is dependent on the extent of tobacco smoke exposure. Carcinogenesis 15:415-418 (1994).
39. Nakachi K, Imai K, Hayashi S, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53:2994-2999 (1993).
40. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Ogreid D, Ulvik A, Phuong Vu, Haugen A. Genotypes of glutathiorie transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18:1285-1289 (1997).
41. Kawajiri K, Eguchi H, Nakachi K, Sekiya T, Yamamoto M. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer. Cancer Res 56:72-76 (1996).
42. Carstensen U, Alexandrie AK, Hogstedt B, Rannug A, Bratt I, Hagmar L. B- and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class mu). Mutat Res 289:187-195 (1993).
43. Ichiba M, Hagmar L, Rannug A, Hogstedt B, Alexandrie AK, Carstensen U, Hemminki K. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis 15:1347-1352 (1994).
44. Hou SM, Lambert B, Hemminki K. Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis 16:1913-1917 (1995).
45. Nielsen PS, Pater N, Okkels H, Autrup H. Environmental air pollution and DNA adducts in Copenhagen bus drivers: effect of GSTM1 and NAT2 genotypes on adduct levels. Carcinogenesis 17:1021-1027 (1996).
46. Hemminki K, Dickey Ch, Karlsson S, Bell D, Hsu Y, Tsai WY, Mooney LVA, Savela K, Perera FP. Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYP1A1 and glutathione transferase M1 genotype. Carcinogenesis 18:345-350 (1997).
47. Gabbani G, Hou SM, Nardini B, Marchioro M, Lambert B, Clonfero E. GSTM1 and TAT2 genotypes and urinary mutagens in coke oven workers. Carcinogenesis 17:1677-1681 (1996).
48. Binková B, Topinka J, Mračková G, Gajdošová D, Vidová P, Dobiáş L, Peterka V, Kalina I, Šrám RJ. Biomarkers in humans exposed to polycyclic aromatic hydrocarbons [Abstract]. Environ Mol Mutagen 29:S5 (1997).
49. Costa DJ, Walsh D, Sanasuttipun W, Lewtas J. Effect of GSTM1 and NAT2 genotypes on white blood cell DNA adduct levels at both high and low PAH exposures [Abstract]. Proc Am Assoc Cancer Res 38:618 (1997).
50. Poirier MC, Rothman N, Schoket B, Pan CF, Shamkhani H, Scott BG, Weston A. Biomarkers of susceptibility and polycyclic aromatic hydrocarbon (PAH) exposure in U.S. Army soldiers [Abstract]. Proc Am Assoc Cancer Res 38:460 (1997).
51. Rothman N, Hayes RB, Zenser TV, DeMarini DM, Bi W, Hirvonen A, Talaska G, Bhatnagar VK, Caporaso NE, Brooks LR et al. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts. Cancer Epidemiol Biomarkers Prev 5:979-983 (1996).
52. Scarpato R, Migliore L, Hirvoven A, Falck G, Norppa H. Cytogenetic monitoring of occupational exposure to pesticides: characterization of GSTM1, GSTT1, and NAT2 genotypes. Environ Mol Mutagen 27:263-269 (1996).
53. Scarpato R, Hirvonen A, Migliore L, Falck G, Norppa H. Influence of GSTM1 and GSTT1 polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers. Mutat Res 389:227-235 (1997).
54. Wiencke JK, Kelsey KT, Lamela RA, Toscano WA Jr. Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res 50:1585-1590 (1990).
55. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterisation of a genetic polymorphism. Biochem J 300:271-276 (1994).
56. Kelsey KT, Wiencke JK, Ward J, Bechtold W, Fajen J. Sister-chromatid exchanges, glutathione S-transferase theta deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutat Res 335:267-273 (1995).
57. Sorsa M, Osterman-Golkar S, Peltonen K, Saarikoski ST, Šrám R. Assessment of exposure to butadiene in the process industry. Toxicology 113:77-83 (1996).
58. Shields PG, Bowman ED, Harrington AM, Doan VT, Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res 53:3486-3492 (1993).
59. Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst 87:902-907 (1995).
60. Santella RM, Perera FP, Young TL, Zhang YJ, Chiamprasert S, Tang D, Wang LW, Beachman A, Lin JH, DeLeo VA. Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype. Mutat Res 334:117-124 (1995).
61. Hirvonen A, Nylund L, Kociba P, Husgafvel-Pursiainen K, Vainio H. Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis 15:813-815 (1994).
62. Grinberg-Funes RA, Singh VN, Perera FP, Bell DA, Young TL, Dickey C, Wang LW, Santella RM. Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and glutathione S-transferase M1 genotype. Carcinogenesis 15:2449-2454 (1994).
63. Mooney LV, Bell DA, Santella RM, VanBennekum AM, Ottman R, Paik M, Blaner WS, Lucier GW, Covey L, Young TL et al. Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis 18:503-509 (1997).
64. VanPoppel G, Verhagen H, VanVeer P, VanBladeren PJ. Markers for cytogenetic damage in smokers: association with plasma antioxidants and glutathione S-transferase μ. Cancer Epidemiol Biomarkers Prev 2:441-447 (1993).
65. Savela K, Piipari R, Hirvonen A, Hayes JD, Anttila S. DNA adducts, glutathione S-transferase (GST) expression, and GSTM1 and GSTP1 polymorphisms in bronchoalveolar macrophages of smokers and non-smokers. Proc Am Assoc Cancer Res 38:451 (1997).
66. Yu MC, Ross RK, Chan KK, Henderson BE, Skipper PL, Tannenbaum SR, Coetzee GA. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black, and Asian smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 4:861-864 (1995).
67. Nielsen PS, Okkels H, Sigsgaard T, Kyrtopoulos S, Autrup H. Exposure to urban and rural air pollution. DNA and protein adducts and effect of glutathione-S-transferase genotype on adduct level. Int Arch Occup Environ Health 68:170-176 (1996).
68. Hou SM, Fält S, Steen AM. Hprt mutant frequency and GSTM1 genotype in non-smoking healthy individuals. Environ Mol Mutagen 25:97-105 (1995).
69. Cheng TJ, Christiani DC, Xu X, Wain JC, Wiencke JK, Kelsey KT. Glutathione S-transferase μ genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes. Cancer Epidemiol Biomarkers Prev 4:535-542 (1995).
70. Cheng TJ, Christiani DC, Wiencke JK, Wain JC, Xu X, Kelsey KT. Comparison of sister chromatid exchange frequency in peripheral lymphocytes in lung cancer cases and controls. Mutat Res 348:75-82 (1995).
71. Cheng TJ, Christiani DC, Liber HL, Wain JC, Xu X, Wiencke JK, Kelsey KT. Mutant frequency at the hprt locus in human lymphocytes in a case-control study of lung cancer. Mutat Res 332:109-118 (1995).
72. Cheng TJ, Christiani DC, Xu X, Wain JC, Wiencke JK, Kelsey KT. Increased micronucleus frequency in lymphocytes from smokers with lung cancer. Mutat Res 349:43-50 (1996).
73. Autrup H, Vestergaard AB, Okkels H. Transplacental transfer of environmental genotoxins: polycyclic aromatic hydrocarbon-albumin in non-smoking women, and the effect of maternal GSTM1 genotype. Carcinogenesis 16:1305-1309 (1995).
74. Sram RJ, Podrazilová K, Dejmek J, Mračková G, Pilčík T. The sensitivity of Comet assay in human population studies. Mutagenesis (in press).
75. Topinka J, Binková B, Mračková G, Stávková Z, Beneš I, Dejmek J, Leníček J, Šrám R. DNA adducts in human placenta as related to air pollution and to GSTM1 genotype. Mutat Res 390:59-68 (1997).
76. Binková B, Lewtas T, Míšková I, Rössner P, Černá M, Mráčková G, Peterková K, Mumford J, Meyer S, Šrám R. Biomarker studies in Northern Bohemia. Environ Health Perspect 104:591-597 (1996).
77. Rothman N, Shields PG, Poirier MC, Harrington AM, Ford DP, Strickland PT. The impact of glutathione S-transferase M1 and cytochrome P450 1A1 genotypes on white-blood-cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans. Mol Carcinogen 14:63-68 (1995).
78. Committee on Biological Markers of the National Research Council. Biological markers in environmental health research. Environ Health Perspect 74:3-9 (1987).
79. Pearce N, de Sanjose S, Boffeta P, Kogevinas M, Saracci R, Saviez D, Limitation of biomarkers of exposure in cancer epidemiology. Epidemiology 6:190-194 (1995).
80. Schulte PA, Perera FP. Transitional studies. In: Application of Biomarkers in Cancer Epidemiology (Toniolo P, Boffetta P, Shuker D, Rothman N, Hulka B, Pearce N, eds). IARC Sci Publ No 142. Lyon:International Agency for Research on Cancer, 1997:19-29.
81. Khoury MS, Adams MJ Jr, Flanders WD. An epidemiologic approach to ecogenetics. Am J Hum Genetics 42:89-95 (1988).
82. Rothman N, Stewart WF, Schulte PA. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiol Biomarkers Prev 4:301-311 (1995).
83. 609C-T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res 57:2839-2842 (1997).
84. Hagmar L, Brogger L, Hansteen IL, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I et al. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54:2919-2922 (1994).
85. Bonassi S, Abbondandolo A, Camuri L, Dal Pra L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C, Padovani P et al. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 79:133-135 (1995).
86. Perera FP. Molecular epidemiology and prevention of cancer. Environ Health Perspect 103(Suppl 8):233-236 (1995).
87. Taninger M, Malacarne D, Mancuso T, Peluso M, Pescarolo MP, Parodi S. Methods for predicting carcinogenic hazards: new opportunities coming from recent developments in molecular oncology and SAR studies. Mutat Res 391:3-32 (1997).
88. Vineis P, Martone T. Genetic-environmental interactions and low-level exposure to carcinogens. Epidemiology 6:455-457 (1995).
89. Wolff S, Jostes R, Cross FT, Hui TE, Afzal V, Wiencke JK. Adaptive response of human lymphocytes for the repair of radon-induced chromosomal damage. Mutat Res 50:299-306 (1991).
90. Perera FP, Hemminki K, Grzybowska E, Motykiewicz G, Michalska J, Santella RM, Young TL, Dickey C, Brandt-Rauf P, DeVivo I et al. Molecular and genetic damage in humans from environmental pollution in Poland. Nature 360:256-258 (1992).
91. Šrám RJ, Beneš I, Binkovǎ B, Dejmek J, Horstman D, Kotěšovec F, Otto D, Perreault SD, Rubeš J, Selevan SG et al. Teplice Program - the impact of air pollution on human health. Environ Health Perspect 104(Suppl 4):699-714 (1996).
92. Natarajan AT, Boi JJWA, Darroudi F, Van Diemen PCM, Dulout F, Hande MP, Ramalho AT. Current cytogenetic methods for detecting exposure and effects of mutagens and carcinogens. Environ Health Perspect 104(Suppl 3):445-448 (1996).